🕵️ ALTO Neuroscience, Inc. ($ANRO)
SEC insider & ownership activity, last 12 months · CIK 1999480 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Joseph Edelman | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Commodore Capital LP | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Commodore Capital Master LP | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Robert Egen Atkinson | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Michael Kramarz | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Sirenia Capital Management LP | 6.2% | 13G | Aug 14, 2026 | filing ↗ | |
| Alex Silverstein | 6.2% | 13G | Aug 14, 2026 | filing ↗ | |
| BlackRock, Inc. | 6.0% | 13G | Jul 27, 2026 | filing ↗ | |
| ECOR1 Capital, LLC | 5.8% | 13G | Jul 20, 2026 | filing ↗ | |
| Oleg Nodelman | 5.8% | 13G | Jul 20, 2026 | filing ↗ | |
| ECOR1 Capital Fund Qualified, L.P. | 5.3% | 13G | Jul 20, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Aug 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 26, 2026 | filing ↗ |
| Earnings (2.02) | Aug 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 13, 2026 | filing ↗ |
| Earnings (2.02) | Jul 13, 2026 | filing ↗ |
| Other events (8.01) | Jul 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 27, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 12, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Other events (8.01) | Apr 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 1, 2026 | filing ↗ |
| Earnings (2.02) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 16, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 16, 2026 | filing ↗ |
| Other events (8.01) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 19, 2025 | filing ↗ |
| Agreement terminated (1.02) | Oct 19, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 19, 2025 | filing ↗ |
| Other events (8.01) | Oct 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 19, 2025 | filing ↗ |